Chargement en cours...
Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data
PURPOSE: Measures derived from longitudinal tumour size data have been increasingly utilised to predict survival of patients with solid tumours. The aim of this study was to examine the prognostic value of such measures for patients with metastatic pancreatic cancer undergoing gemcitabine therapy. M...
Enregistré dans:
| Publié dans: | Cancer Chemother Pharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844653/ https://ncbi.nlm.nih.gov/pubmed/26940939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-2994-x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|